MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.340
-0.040 (-1.18%)
At close: Mar 10, 2026, 4:00 PM EDT
3.450
+0.110 (3.29%)
After-hours: Mar 10, 2026, 7:58 PM EDT
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $171.56 million as of March 10, 2026. Its market cap has increased by 95.05% in one year.
Market Cap
171.56M
Enterprise Value
229.13M
1-Year Change
95.05%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $171.56M, a decrease of -36.28%. That is a compound annual growth rate of -4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 173.61M | -1.75% |
| Dec 31, 2025 | 176.71M | 57.67% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 820.31M |
| Castle Biosciences | 806.31M |
| Myriad Genetics | 481.57M |
| Fulgent Genetics | 456.90M |
| Prenetics Global | 299.55M |
| Burning Rock Biotech | 239.56M |
| Biodesix | 185.14M |
| Insight Molecular Diagnostics | 175.31M |